Thermo Fisher Scientific Future Growth
Future criteria checks 1/6
Thermo Fisher Scientific is forecast to grow earnings and revenue by 15.5% and 6.2% per annum respectively while EPS is expected to grow by 16.4% per annum.
Key information
15.5%
Earnings growth rate
16.4%
EPS growth rate
Life Sciences earnings growth | 0% |
Revenue growth rate | 6.2% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 06 Jul 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 52,593 | 9,637 | 9,584 | 11,639 | 19 |
12/31/2024 | 48,780 | 8,383 | 8,682 | 10,662 | 23 |
12/31/2023 | 45,267 | 6,852 | 6,821 | 8,788 | 24 |
4/1/2023 | 43,807 | 6,024 | 5,620 | 7,681 | N/A |
12/31/2022 | 44,915 | 6,950 | 6,911 | 9,154 | N/A |
10/1/2022 | 44,167 | 7,032 | 5,600 | 8,124 | N/A |
7/2/2022 | 42,820 | 7,439 | 6,336 | 8,837 | N/A |
4/2/2022 | 41,123 | 7,603 | 7,001 | 9,536 | N/A |
12/31/2021 | 39,211 | 7,725 | 6,789 | 9,312 | N/A |
10/2/2021 | 39,059 | 8,565 | 7,916 | 10,194 | N/A |
7/3/2021 | 38,250 | 8,596 | 8,132 | 10,252 | N/A |
4/3/2021 | 35,894 | 7,924 | 8,062 | 9,911 | N/A |
12/31/2020 | 32,218 | 6,375 | 6,815 | 8,289 | N/A |
9/26/2020 | 28,497 | 4,879 | 5,686 | 6,863 | N/A |
6/27/2020 | 26,248 | 3,706 | 4,245 | 5,272 | N/A |
3/28/2020 | 25,647 | 3,669 | 3,702 | 4,680 | N/A |
12/31/2019 | 25,542 | 3,696 | 4,047 | 4,973 | N/A |
9/28/2019 | 25,220 | 3,592 | 3,940 | 4,861 | N/A |
6/29/2019 | 24,868 | 3,541 | 4,086 | 4,964 | N/A |
3/30/2019 | 24,630 | 3,174 | 4,273 | 5,114 | N/A |
12/31/2018 | 24,358 | 2,938 | 3,785 | 4,543 | N/A |
9/29/2018 | 23,898 | 2,570 | 3,919 | 4,608 | N/A |
6/30/2018 | 23,094 | 2,395 | 3,689 | 4,317 | N/A |
3/31/2018 | 22,006 | 2,256 | 3,189 | 3,722 | N/A |
12/31/2017 | 20,918 | 2,228 | 3,497 | 4,005 | N/A |
9/30/2017 | 19,824 | 2,330 | 2,918 | 3,344 | N/A |
7/1/2017 | 19,199 | 2,270 | 2,825 | 3,220 | N/A |
4/1/2017 | 18,744 | 2,174 | 2,862 | 3,284 | N/A |
12/31/2016 | 18,274 | 2,025 | N/A | 3,258 | N/A |
10/1/2016 | 17,973 | 1,999 | N/A | 3,281 | N/A |
7/2/2016 | 17,606 | 2,003 | N/A | 3,220 | N/A |
4/2/2016 | 17,341 | 1,998 | N/A | 3,072 | N/A |
12/31/2015 | 16,965 | 1,980 | N/A | 2,942 | N/A |
9/26/2015 | 16,806 | 1,978 | N/A | 2,543 | N/A |
6/27/2015 | 16,854 | 1,971 | N/A | 2,475 | N/A |
3/28/2015 | 16,905 | 1,738 | N/A | 2,598 | N/A |
12/31/2014 | 16,890 | 1,896 | N/A | 2,620 | N/A |
9/27/2014 | 15,864 | 1,635 | N/A | 2,394 | N/A |
6/28/2014 | 14,884 | 1,482 | N/A | 2,224 | N/A |
3/29/2014 | 13,802 | 1,481 | N/A | 1,814 | N/A |
12/31/2013 | 13,090 | 1,279 | N/A | 2,011 | N/A |
9/28/2013 | 12,883 | 1,322 | N/A | 1,942 | N/A |
6/29/2013 | 12,777 | 1,304 | N/A | 1,917 | N/A |
3/30/2013 | 12,645 | 1,318 | N/A | 1,946 | N/A |
12/31/2012 | 12,510 | 1,258 | N/A | 2,040 | N/A |
9/29/2012 | 12,340 | 1,165 | N/A | 2,016 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TMOD's forecast earnings growth (15.5% per year) is above the savings rate (8.3%).
Earnings vs Market: TMOD's earnings (15.5% per year) are forecast to grow slower than the AR market (33.3% per year).
High Growth Earnings: TMOD's earnings are forecast to grow, but not significantly.
Revenue vs Market: TMOD's revenue (6.2% per year) is forecast to grow slower than the AR market (33.6% per year).
High Growth Revenue: TMOD's revenue (6.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TMOD's Return on Equity is forecast to be high in 3 years time